Jaydutt V. Vadgama - Concepedia

Author

Jaydutt V. Vadgama

Charles R. Drew University of Medicine and Science

Also Known As

Guangdi Wang, J V Vadgama, J Vadgama, J. V. VADGAMA, J. V. Vadgama, J.V. Vadgama, JAY VADGAMA, JAYDUTT V VADGAMA, JAYDUTT V. VADGAMA, JAYDUTT VADGAMA

291

Publications

6.1K

Citations

H-Index

109

Concepts

All Affiliations

Charles R. Drew University of Medicine and Science University of California, Los Angeles UCLA Jonsson Comprehensive Cancer Center Cedars-Sinai Medical Center UCLA Medical Center

About

Jaydutt V. Vadgama is an author at Charles R. Drew University of Medicine and Science specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	35	2K
2	Health Sciences	9	9	616
3	Natural Sciences	4	4	148
4	Engineering	1	1	36
5	Public Health	1	1	24

Jaydutt V. Vadgama

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
Expression of Wnt3 Activates Wnt/β-Catenin Pathway and Promotes EMT-like Phenotype in Trastuzumab-Resistant HER2-Overexpressing Breast Cancer Cells Yanyuan Wu, Charles Ginther, Juri Kim, Molecular Cancer Research Breast OncologyEmt-like TransitionCancer BiologyTumor BiologySignaling Pathway	2012	263
Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NFκB signaling. Seyung Chung, Jaydutt V. Vadgama PubMed	2015	183
Impaired actions of insulin-like growth factor 1 on protein Synthesis and degradation in skeletal muscle of rats with chronic renal failure. Evidence for a postreceptor defect. Heyuan Ding, Xiulin Gao, Raimund Hirschberg, Journal of Clinical Investigation Renal PathologyRenal InflammationInsulin SignalingProtein SynthesisSkeletal Muscle Resistance	1996	176
STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits Seyung Chung, Nolan Giehl, Yanyuan Wu, International Journal of Oncology Breast OncologyCancer BiologyCancer StemTumor BiologyStem Cell Markers	2013	157
Critical role of oxidative stress in estrogen-induced carcinogenesis Hari K. Bhat, Gloria M. Calaf, Tom K. Hei, Proceedings of the National Academy of Sciences	2003	131
Response of Breast Cancer Cells to PARP Inhibitors Is Independent of BRCA Status Man Yee Keung, Yanyuan Wu, Francesca Badar, Journal of Clinical Medicine Breast OncologyOncologyDifferent ParpiMedicineBreast Cancer Cells	2020	119
Plasma Insulin-Like Growth Factor-I and Serum IGF-Binding Protein 3 Can Be Associated with the Progression of Breast Cancer, and Predict the Risk of Recurrence and the Probability of Survival in African-American and Hispanic Women Jaydutt V. Vadgama, Yanyuan Wu, Geetanjali D. Datta, Oncology Hispanic WomenBreast OncologyCancer RiskCancer EpidemiologyMedicine	1999	111
MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis Pranabananda Dutta, Marianna Sarkissyan, Kimberly Paico, Breast Cancer Research and Treatment	2018	111
Proinflammatory Cytokines IL-6 and TNF-<i>α</i>Increased Telomerase Activity through NF-<i>κ</i>B/STAT1/STAT3 Activation, and Withaferin A Inhibited the Signaling in Colorectal Cancer Cells Seyung Chung, Yong Wu, Quincy Okobi, Mediators of Inflammation	2017	105
Constitutive Activation of STAT3 Signaling Regulates hTERT and Promotes Stem Cell-Like Traits in Human Breast Cancer Cells Seyung Chung, Clement Aroh, Jaydutt V. Vadgama PLoS ONE Breast OncologyCancer Stem CellCancer BiologyTumor BiologyTranscriptional Regulation	2013	100

Page 1